New cancer drugs are making headlines

New cancer drugs are making headlines...Iressa, Velcade, Avastin.

They each have an important new mechanism of action.

Iressa (gefitinib) is a new oral drug for lung cancer.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote